How do you counsel patients eligible for the RSV vaccines? What do the results of the RENOIR and AReSVi trials tell us and how do they compare? How should we interpret vaccine trials in the first place? Tune in to the fourth episode of Beyond Journal Club, a new series brought to you by Core IM in collaboration with NEJM Group.
Sponsor: Pathway FREE evidence-based clinical decision support app. Guideline summaries, interactive algorithms, landmark trials & more
Show Notes & Transcript
Time Stamps:
(02:30) | Epidemiology of RSV
(03:46) | Development of RSV vaccine
(05:55) | Vaccine trial design
(12:22) | ARESVI and RENOIR Trials
(18:18) | Who should we recommend the RSV vaccine to?
(19:50) | What don’t we know?
Tags: IMCore, CoreIM, primary care, infectious disease, nurse practitioner, pharmacist, physician assistant
Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840
Our Sponsors:
* Check out Eko Core 500 Digital Stethoscope: https://ekohealth.com/COREIM
* Check out FIGS and use code FIGSRX for 15% off your 1st order: https://wearfigs.com
* Check out Washington Red Raspberries for recipes, farmers' stories, and which grocery stores carry: https://www.coreimpodcast.com/redrazz
Advertising Inquiries:
https://redcircle.com/brandsPrivacy & Opt-Out:
https://redcircle.com/privacy
